Elemer Piros retweeted
#AlphaNooner – Deep Dive into Psychedelic Biotech with Elemer Piros, PhD xitter.gq/i/broadcasts/1mnxegpqE…
Elemer Piros retweeted
Check out our most recent interview with @ElemerPiros to learn more about the significance of these results!
youtube.com/watch?v=7_-44xF7…
📣 Excited to announce positive data from our latest SSRI drug interaction study 📣 Results show 92% of patients on #SSRI medication were in remission from #depression 4 weeks after a dose of SPL026 (DMT) with support therapy.
Link to press release 👉 smallpharma.com/press-releas…
Elemer Piros retweeted
Appreciate you being such a strong advocate for this sector @ElemerPiros
Elemer Piros retweeted
📣 Excited to announce positive data from our latest SSRI drug interaction study 📣 Results show 92% of patients on #SSRI medication were in remission from #depression 4 weeks after a dose of SPL026 (DMT) with support therapy.
Link to press release 👉 smallpharma.com/press-releas…
Elemer Piros retweeted
Congratulations. Impressive.
📣 Excited to announce positive data from our latest SSRI drug interaction study 📣 Results show 92% of patients on #SSRI medication were in remission from #depression 4 weeks after a dose of SPL026 (DMT) with support therapy.
Link to press release 👉 smallpharma.com/press-releas…
Elemer Piros retweeted
In case you missed it, here is our most recent interview with @insidepharma talking about @CybinInc's $CYBN acquisition of @SmallPharma $DMTTF. Point 72 recently bought over 18 million shares in $CYBN. This is big time news. CYB003 results coming soon.
youtube.com/watch?v=1OceEJRC…
Elemer Piros retweeted
Steve Cohen is in town $CYBN
sec.gov/Archives/edgar/data/…
Psilocybin works even better in MDD vs TRD!
Single-Dose Psilocybin Treatment for Major Depressive Disorder jamanetwork.com/journals/jam…
Elemer Piros retweeted
$CYBN will be the clear leader in the psychedelic drug development sector, with the largest IP portfolio of any company in the industry! This portfolio includes 28 patents that have already been granted and 158 patents that are pending approval. These patents cover a wide range of psychedelic compounds and technologies, giving Cybin a significant competitive advantage in the development of new psychedelic therapeutics.
Elemer Piros retweeted
Will DMT be a medicine in the UK? 💊 Dr. Carol Routledge from Small Pharma Labs speaks with Prof David Nutt in our latest Drug Science podcast episode.
👂 Listen here: drugscience.org.uk/podcast/8…
Elemer Piros retweeted
With VLS-01, @atai_life, $ATAI, is trying to extend the duration of NN-DMT out to around 45 minutes by having the drug delivered on an oral transmucosal film(produced by @IntelGenx). The company is also looking to combine VLS-01 with digital therapeutics.
youtube.com/watch?v=WAG0jq9p…
Elemer Piros retweeted
We got the opportunity to speak with senior Biotechnology analyst at EF Hutton, @ElemerPiros. Mr. Piros received his PhD in Neuroscience from UCLA and has been analyzing Biotechnology companies for over 20 years. youtube.com/watch?v=6WPRFwet…
Elemer Piros retweeted
1/ The short acting psychedelic DMT might induce long term improvements in depression, according to new preliminary data. These are the first data showing that a psychedelic experience of around 30 mins might have therapeutic potential. Below a breakdown of results:
Elemer Piros retweeted
Greg Mayes, CEO of Reunion, Sits in the Investor Hotseat on January 16th xitter.gq/i/broadcasts/1zqKVPVvR…
Elemer Piros retweeted
$ARRY (+10.9% pre) Array Biopharma (ARRY) Announces BRAFTOVI + MEKTOVI + Cetuximab Meet Primary Endpoints of ORR and OS in Phase 3 BEACON CRC Trial - SI
ooc.bz/l/37256
Elemer Piros retweeted
.@jongoodall #mayweathervmcgregor Couldn't afford Vegas so watching at home 😎 pscp.tv/jongoodall/1DXGyOyLL…
Elemer Piros retweeted
"We really are moving away from this one drug, one biomarker, one companion diagnostic," FDA's Pazdur - buff.ly/1pM6S2t